1. Williams DL, Look AT, Melvin SL, Roberson PK, Dahl G, Flake T, et al. New chromosomal translocations correlate with specific immunophenotypes of childhood acute lymphoblastic leukemia. Cell. 1984. 36:101–109.
Article
2. Borowitz MJ, Chan JKC. Swerdlow SH, Harris NL, editors. Blymphoblastic leukemia/lymphoma with recurrent genetic abnormalities. WHO classification of tumours of haematopoietic and lymphoid tissues. 2008. 4th ed. Lyon: International Agency for Research on Cancer;171–175.
3. Khalidi HS, O'Donnell MR, Slovak ML, Arber DA. Adult precursor-B acute lymphoblastic leukemia with translocations involving chromosome band 19p13 is associated with poor prognosis. Cancer Genet Cytogenet. 1999. 109:58–65.
Article
4. Kamps MP, Murre C, Sun XH, Baltimore D. A new homeobox gene contributes the DNA binding domain of the t(1;19) translocation protein in pre-B ALL. Cell. 1990. 60:547–555.
Article
5. Crist WM, Carroll AJ, Shuster JJ, Behm FG, Whitehead M, Vietti TJ, et al. Poor prognosis of children with preB acute lymphoblastic leukemia is associated with the t(1;19)(q23;p13): a Pediatric Oncology Group study. Blood. 1990. 76:117–122.
Article
6. Lanza C, Gottardi E, Gaidano G, Vivenza C, Parziale A, Perfetto F, et al. Persistence of E2A/PBX 1 transcripts in t(1;19) childhood acute lymphoblas tic leukemia: correlation with chemotherapy intensity and clinical outcome. Leuk Res. 1996. 20:441–443.
Article
7. Orazi A, Cattoretti G, Heerema NA, Sozzi G, John K, Neiman RS. Frequent p53 overexpression in therapy related myelodysplastic syndromes and acute myeloid leukemias: an immunohistochemical study of bone marrow biopsies. Mod Pathol. 1993. 6:521–525.
8. Vagner-Capodano AM, Mozziconacci MJ, Zattara-Cannoni H, Guitard AM, Thuret I, Michel G. t(1;19) in a M4ANLL. Cancer Genet Cytogenet. 1994. 73:86–88.
Article
9. Mitani K, Sasaki K, Ogawa S, Hayashi Y, Mano H, Yazaki Y, et al. Molecular analysis of the t(1;19)(q23;p13) translocation observed in adult leukemias. Int J Hematol. 1994. 60:267–271.
10. Creutzig U, Ritter J, Vormoor J, Ludwig WD, Niemeyer C, Reinisch I, et al. Myelodysplasia and acute myelogenous leukemia in Down's syndrome. A report of 40 children of the AMLBFM study group. Leukemia. 1996. 10:1677–1686.
11. Weh HJ, Jonveaux P, Seeger D, Felgner J, Hossfeld DK. t(1;19)(q23;p13) in a case of acute monocytic leukemia. Cancer Genet Cytogenet. 1996. 87:52–54.
Article
12. Keung YK, Knovich MA, Powell BL, Buss DH, Pettenati M. Constitutional pericentric inversion of chromosome 9 and acute leukemia. Cancer Genet Cytogenet. 2003. 145:82–85.
13. Gozzetti A, Calabrese S, Raspadori D, Crupi R, Tassi M, Bocchia M, et al. Concomitant t(4;11) and t(1;19) in a patient with biphenotypic acute leukemia. Cancer Genet Cytogenet. 2007. 177:81–82.
Article
14. Boyd EM, Bench AJ, Vaghela KJ, Campbell GN, Chowdhury FB, Gudgin EJ, et al. Therapyrelated acute myeloid leukaemia with t(8;16)(p11;p13);MOZCBP and polymorphisms in detoxifying and DNA repair genes. Leukemia. 2009. 23:1164–1167.
Article
15. Gerr H, Zimmermann M, Schrappe M, Dworzak M, Ludwig WD, Bradtke J, et al. Acute leukaemias of ambiguous lineage in children: characterization, prognosis and therapy recommendations. Br J Haematol. 2010. 149:84–92.
Article
16. Murugesan G, Aboudola S, Szpurka H, Verbic MA, Maciejewski JP, Tubbs RR, et al. Identification of the JAK2 V617F mutation in chronic myeloproliferative disorders using FRET probes and melting curve analysis. Am J Clin Pathol. 2006. 125:625–633.
Article
17. Privitera E, Kamps MP, Hayashi Y, Inaba T, Shapiro LH, Raimondi SC, et al. Different molecular consequences of the 1;19 chromosomal translocation in childhood Bcell precursor acute lymphoblastic leukemia. Blood. 1992. 79:1781–1788.
Article
18. Pui CH, Raimondi SC, Hancock ML, Rivera GK, Ribeiro RC, Mahmoud HH, et al. Immunologic, cytogenetic, and clinical characterization of childhood acute lymphoblastic leukemia with the t(1;19)(q23; p13) or its derivative. J Clin Oncol. 1994. 12:2601–2606.
Article
20. Hunger SP, Galili N, Carroll AJ, Crist WM, Link MP, Cleary ML. The t(1;19)(q23;p13) results in consistent fusion of E2A and PBX1 coding sequences in acute lymphoblastic leukemias. Blood. 1991. 77:687–693.
Article
21. Izraeli S, Janssen JW, Haas OA, Harbott J, Brok-Simoni F, Walther JU, et al. Detection and clinical relevance of genetic abnormalities in pediatric acute lymphoblastic leukemia: a comparison between cytogenetic and polymerase chain reaction analyses. Leukemia. 1993. 7:671–678.
22. Paulsson K, Jonson T, Ora I, Olofsson T, Panagopoulos I, Johansson B. Characterisation of genomic translocation breakpoints and identification of an alternative TCF3/PBX1 fusion transcript in t(1;19)(q23;p13)-positive acute lymphoblastic leukaemias. Br J Haematol. 2007. 138:196–201.
Article